Falk Nimmerjahn PhD

Falk Nimmerjahn was trained in molecular biology, genetics and immunology at the Universities of Bayreuth, Erlangen-Nuremberg, and Munich, where he obtained his PhD. After two years of postdoctoral training at the Helmholtz Centre Munich he joined Prof. Ravetchs’ laboratory in New York in 2004, where he studied how different IgG subclasses mediate their activity in vivo and how IgG glycosylation impacts antibody activity. In 2007 he was appointed as an associate professor at the University Hospital of Erlangen and head of the laboratory of Experimental Immunology and Immunotherapy. In 2010 he became full professor and chairman of the Institute of Genetics at the Friedrich-Alexander University of Erlangen-Nuremberg. His group has several major areas of interest, all focusing on a better understanding of how immunoglobulin G (IgG) antibodies work in mice and humans in vivo.